methylprednisolone has been researched along with berotek in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (42.86) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chaudhary, BA; Kolbeck, RC; Speir, WA | 1 |
| Fügner, A | 1 |
| Petracca, E; Ramazzina, E; Zennaro, R | 1 |
| de Castro del Pozo, S; Díez Jarilla, JL; González Macías, J; Laso Guzmán, FJ; Martín Rodríguez, M | 1 |
| Anthonisen, NR; Arnup, ME; Mendella, LA | 1 |
| Cruz Hernández, JJ; de Portugal Alvarez, J; del Pino Montes, J; Díez Jarilla, JL; Sánchez Gascón, F | 1 |
| Bomans, P; Daenen, M; Decramer, M; Verleden, G; Willaert, W | 1 |
| Atehortúa, DA; Buendía, JA; Montoya, DV; Montoya-Giraldo, MA; Zuluaga, AF | 1 |
1 trial(s) available for methylprednisolone and berotek
| Article | Year |
|---|---|
What is the optimal treatment strategy for chronic obstructive pulmonary disease exacerbations?
Topics: Acute Disease; Aged; Albuterol; Bronchodilator Agents; Dyspnea; Female; Fenoterol; Glucocorticoids; Humans; Ipratropium; Male; Metered Dose Inhalers; Methylprednisolone; Patient Readmission; Patient Satisfaction; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quality of Life; Spirometry; Treatment Failure | 2002 |
13 other study(ies) available for methylprednisolone and berotek
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Effect of glucocorticoids on the response of airway smooth muscle to catecholamine and resorcinol beta-agonists.
Topics: Adrenergic beta-Antagonists; Animals; Catecholamines; Fenoterol; Glucocorticoids; Guinea Pigs; Hydrocortisone; In Vitro Techniques; Isoproterenol; Male; Methylprednisolone; Muscle Contraction; Muscle, Smooth; Piperidines; Resorcinols; Terbutaline; Trachea | 1989 |
Formation of oedema and accumulation of eosinophils in the guinea pig lung. Inhibition by inhaled beta-stimulants.
Topics: Acetylcholine; Animals; Benzimidazoles; Bronchial Spasm; Bronchoalveolar Lavage Fluid; Capillary Permeability; Edema; Eosinophils; Fenoterol; Guinea Pigs; Indomethacin; Lung; Methylprednisolone; Pyrazoles | 1989 |
[Recovery of bronchial sensitivity to sympathomimetics after administration of corticosteroids].
Topics: Adrenal Cortex Hormones; Aged; Bronchi; Bronchitis; Female; Fenoterol; Forced Expiratory Volume; Humans; Male; Methylprednisolone; Middle Aged; Receptors, Adrenergic, beta; Sympathomimetics; Vital Capacity | 1988 |
[The adenyl cyclase system in asthmatic patients (II). Urinary excretion of cyclic AMP following the simultaneous administration of a corticoid and a beta-2 adrenergic agonist].
Topics: Adenylyl Cyclases; Asthma; Cyclic AMP; Drug Interactions; Ethanolamines; Fenoterol; Humans; Methylprednisolone | 1983 |
Effects of cold air hyperpnea in patients with chronic obstructive lung disease.
Topics: Aged; Airway Resistance; Albuterol; Bronchi; Cold Temperature; Female; Fenoterol; Forced Expiratory Volume; Humans; Lung Diseases, Obstructive; Male; Metaproterenol; Methylprednisolone; Middle Aged; Respiration | 1983 |
[Corticoids and selective beta 2-agonists: spirometric synergism and oxymetric antagonism].
Topics: Drug Therapy, Combination; Ethanolamines; Fenoterol; Humans; Lung Diseases, Obstructive; Methylprednisolone | 1982 |
Myoclonus induced by salbutamol: A case report
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Combined Modality Therapy; Drug Synergism; Drug Therapy, Combination; Emergencies; Fatal Outcome; Fenoterol; Humans; Ipratropium; Male; Methylprednisolone; Middle Aged; Myoclonus; Oxygen Inhalation Therapy; Pulmonary Disease, Chronic Obstructive; Substance-Related Disorders | 2018 |